Board of Directors is pleased to announce the appointment of Wesley P.  Wheeler, MBA as Chief Executive Officer. Mr. Wheeler succeeds Gerard Barba, who willremain the Chairman of the Marken Board of Directors. 

Marken’s Board and executive management team have sought to add an executive such  as Mr. Wheeler for his in depth of experience in the life science industry as well as a  strong background in logistics to further strengthen market leadership and maintain  Marken’s  growth path.

Prior to joining Marken, Wes held the title of President and CEO of Patheon Inc., a contract manufacturing services company. Wes was also a former President of Valeant  Pharmaceuticals International, and has previously held senior executive roles of  increasing responsibility in manufacturing, marketing and engineering at GlaxoSmithKline,  plc. Preceding his 22 year career in pharmaceuticals, Mr. Wheeler had a successful 12  year career at ExxonMobil. He holds a bachelor’s degree in Mechanical Engineering and aMasters of Business Administration.

 “As the nature of biopharmaceutical R&D changes, well controlled clinical supply chains will  be a significant factor in the success of key life science companies and the industries that  support them. The Board and I feel that Wes can bring his experience from the drug  manufacturing, biotechnology, and traditional pharmaceutical industries to augment an already strong management team and continue Marken’s growth”, said Gerard Barba,Marken’s Chairman.